alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2


CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Beyond Commerce, Inc. (the “Company”) on
Form 10-Q for the period ended March 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Mark V. Noffke, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:




(1)
            The Report fully complies with
      the requirements of section 13(a) or 15(d) of the Securities Exchange Act
      of 1934; and





(2)
            The information contained in the
      Report fairly presents, in all material respects, the financial condition
      and results of operations of the
Company.




Date:
      May 15, 2009
            By:
            /s/ Mark V.
      NoffkeMark
      V. Noffke
              Chief Financial Officer
              (principal financial officer)
QuickLinks
 -- Click here to rapidly navigate through this document









































 Exhibit 10.2.1  


 
 

  AMENDMENT TO THE
  EMPLOYMENT AGREEMENT WITH DON S. HARVEY    
    


        WHEREAS, Emergency Medical Services, L.P. ("Purchaser") and Don S. Harvey ("Executive") entered into an Employment Agreement
("Agreement") on February 10, 2005, as amended; and 


        WHEREAS,
the Purchaser and the Executive desire to amend the Agreement to reflect compliance with the provisions of Section 409A of the Internal Revenue Code of 1986, as amended. 


        NOW,
THEREFORE, the Agreement is hereby amended effective January 1, 2009 as follows: 


        1.     The
third sentence of Section 6(a)(i) is deleted and replaced with the following: 




Upon
such termination, Purchaser may elect, in its sole and absolute discretion, to pay the Executive his Base Salary in effect at the time of such termination for a period of up to 24 months
following such termination as consideration for Executive's agreement set forth in paragraph (b) of this Article 6, and any such payment shall be made on the Purchaser's regularly
scheduled payroll dates during such period. Notwithstanding anything herein to the contrary, in the event that Executive is determined to be a specified employee within the meaning of
Section 409A of the Internal Revenue Code of 1986, as amended ("Code") for purposes of any payment on termination of employment hereunder, payment
shall be made or begin, as applicable, on the first payroll date which is more than six months following the date of separation from service, to the extent required to avoid any adverse tax
consequences under Section 409A of the Code. 





IN
WITNESS WHEREOF, Purchaser and Executive have executed this Agreement, in multiple counterparts, each of which shall be deemed an original, this 30th day of December, 2008 and effective
January 1, 2009. 



							
	
 PURCHASER	
 	
ATTEST:
	
 By:	
 	
/s/ William A. Sanger







 	
 	
By:	
 	








 
	
 Its:	
 	
CEO and Chairman, EMSC







 	
 	
Its:	
 	








 






 





							
	

EXECUTIVE	
 	

 	
 	

 
	

/s/ Don S. Harvey








 	
 	

 	
 	

 
	
 Print:	
 	
Don S. Harvey







 	
 	

 	
 	

 














QuickLinks


AMENDMENT TO THE EMPLOYMENT AGREEMENT WITH DON S. HARVEY
Exhibit 10.6






Exhibit 10.6









	 	 	 
	DATE: February 23, 2009

	 	TIME: 08:44:12
	ESCROW NO: 521434-CL
	 	 
	ESCROW OFFICER: Carolyn Lamascus

	 	CLOSING DATE: February 20, 2009






BUYER FINAL CLOSING STATEMENT




SELLER(S): Hovic Perian and Rima Perian

BUYER(S): Fontana Medical Plaza

PROPERTY: 17590 Foothill Boulevard, Fontana, CA 92335




	 	 	 	 	 	 	 	 	 
	 	 	$ DEBITS	 	 	$ CREDITS	 
	FINANCIAL:
	 	 	 	 	 	 	 	 
	Total Consideration
	 	 	1,900,000.00	 	 	 	 	 
	Deposit – Philip Elghanian or Assignee
	 	 	 	 	 	 	50,000.00	 
	Deposit – Screenland Development
	 	 	 	 	 	 	19,800.00	 
	Deposit – Fontana Medical Plaza
	 	 	 	 	 	 	1,100,000.00	 
	Deposit – Fontana Medical Plaza
	 	 	 	 	 	 	834,953.74	 
	 
	 	 	 	 	 	 	 	 
	PRORATIONS/ADJUSTMENTS:
	 	 	 	 	 	 	 	 
	Prepaid County Taxes at $9,351.40
Semi-Annual from 02/20/09 to 07/01/09
	 	 	6,805.74	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	TITLE CHARGES:
	 	 	 	 	 	 	 	 
	CLTA Standard Coverage Policy – 1990 for 1,900,000.00
	 	 	3,178.00	 	 	 	 	 
	
Documentary Transfer Tax
	 	 	2,090.00	 	 	 	 	 
	Recording Deed
	 	 	15.00	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	ESCROW CHARGES
	 	 	 	 	 	 	 	 
	Escrow Fee
	 	 	2,500	 	 	 	 	 
	Express Mail
	 	 	11.45	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	MISCELLANEOUS CHARGES:
	 	 	 	 	 	 	 	 
	Hovic & Rima Perian Extension Fees
	 	 	19,800.00	 	 	 	 	 
	Screenland Development Group, LLC
Refund of deposit
	 	 	19,800.00	 	 	 	 	 
	Philip Elghanian Refund of deposit
	 	 	50,000.00	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	BUYERS REFUND
	 	$	553.55	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	TOTALS
	 	$	2,004,753.74	 	 	$	2,004,753.74	 






SAVE THIS STATEMENT FOR INCOME TAX PURPOSES
```
[Federal Register Volume 61, Number 123 (Tuesday, June 25, 1996)]
[Notices]
[Page 32862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-16061]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (CenterPoint Properties Corporation, Common Stock, 
$0.001, Par Value; 8.22% Convertible Subordinated Debentures Due 2004) 
File No. 1-12630

June 19, 1996.
    CenterPoint Properties Corporation (``Company'') has filed an 
application with the Securities and Exchange Commission 
(``Commission''), pursuant to Section 12(d) of the Securities Exchange 
Act of 1934 (``Act'') and Rule 12d2-2(d) promulgated thereunder to 
withdraw the above specified securities (``Securities'') from listing 
and registration on the American Stock Exchange, Inc. (``Amex'').
    The reasons alleged in the application for withdrawing the 
Securities from listing and registration include the following:
    According to the Company, it has listed the Security with the New 
York Stock Exchange, Inc. (``NYSE''). In making the decision to 
withdraw the Securities from listing on the Amex, the Company 
considered the direct and indirect costs and expenses attendant on 
maintaining the dual listing of the Securities on the NYSE and on the 
Amex. The Company does not see any particular advantage in the dual 
trading of the Securities and believes that dual listing would fragment 
the market for its Securities.
    Any interested person may, on or before July 11, 1996, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether 
the application has been made in accordance with the rules of the 
exchanges and what terms, if any, should be imposed by the Commission 
for the protection investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 96-16061 Filed 6-24-96; 8:45 am]
BILLING CODE 8010-01-M
```
Exhibit B

Filed Under Seal

Case 2:18-cr-00422-DJH Document 1281-2 Filed 09/09/21 Page 1 of 1
October 25, 2023

Sent via email to:

The Honorable Diane J. Humetewa

United States District Court- Pheonix Division

Sandra Day O'Connor U. S. Courthouse

401 W. Jefferson Strett, SPC 625

Courtroom 605

Phoenix, AZ 85004 

humetewa_chambers@azd.uscourts.gov 

Criminal Justice Act (CJA) Unit- Phoenix Division 

cja_evoucher@azd.uscourts.gov 

Re: USA v. Michael Lacey, et al., CR18-00422-PHX-DJH

Letter of Explanation for Daily Transcript Request 

Your Honor:

CJA Defense counsel is respectfully requesting the daily transcripts for all remaining trial 

days beginning October 25, 2023, through the conclusion of the case. I am requesting a 

daily-turnaround. The reason for the expeditious turnaround time is due to the numerous 

evidentiary rulings and guidance by the Court regarding subject matters that are or are not

permissable. The transcripts are necessary for effective examination within the evidentiary 

bounds set by this Court. 

Thank you.

Sincerely,

Eric W. Kessler

EWK/jk

Case 2:18-cr-00422-DJH Document 1910-1 Filed 10/25/23 Page 1 of 1
Exhibit
13.1




CERTIFICATION


Pursuant
to 18 U.S.C. Section 1350


as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





InconnectionwiththeAnnualReportofChinaSouthernAirlinesCompanyLimited(the“Company”)onForm20-FfortheyearendedDecember31,2009asfiledwiththeSecuritiesandExchangeCommissiononthedatehereof (the “Report”), I,
Tan Wan Geng, President of the Company, hereby certify, pursuant to 18 U.S.C. §
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to
the best of my knowledge, that:




1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:
      May 28, 2010
              By:
              /s/
      Tan Wan GengName:
      Tan Wan GengTitle:
      President




* This
certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act
of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act
of 2002, be deemed filed by the Company for purposes of §18 of the Securities
Exchange Act of 1934, as amended.




* A
signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.
Exhibit 32.2

JMP GROUP INC.

CERTIFICATION OF
CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

In
connection with the periodic report of JMP Group Inc. (the Company) on Form 10-Q for the period ended June 30, 2010, as filed with the Securities and Exchange Commission (the Report), I, Raymond S. Jackson, Chief
Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:



| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for
the periods indicated.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |  |  |                        
|-------------------- |  |  |  | -----------------------
|                     |  | 
|Date: August 4, 2010 |  |  |  | /s/ Raymond S. Jackson 
|                     |  |  |  | Raymond S. Jackson     
|                     |  |  |  | Chief Financial Officer

This certification accompanies
this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act).
Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
exhibit10_24.htm


    Exhibit
10.24

                                          

     

    
    

     

    
      	
               

              

               

            	 	 	 
	 	 	 	 Dustan E.
  McCoy
	 October 7,
      2008      	 	 	 Chairman
      and Chief Executive Officer


    

     

     

     

    Inisfail
Consulting

    Attn:  Mr.
Patrick C. Mackey

    1
Beachview

    County
Donegal

    Fahan,
Ireland

    


    Re: Consulting
Services

    


    Dear
Pat:

    


    As we discussed, this
confirms that Brunswick Corporation would like to retain Inisfail Consulting
{the “Firm”} to provide consulting services (the “Services”) to John Pfeifer and
his team in connection with Brunswick’s evaluation of its European manufacturing
footprint (the “Project).  The Services will be provided as requested
by John Pfeifer from time to time, and at a paid fee of $3,500 (USD) for each
day of Services provided, plus reasonable expenses incurred in connection
with the rendering of the Services.

    


    You agree
that the Firm will provide the Services in a professional manner, will comply
with all applicable laws and policies of Brunswick, and will represent
Brunswick’s interests, to the best of its ability.  The Firm will act
at all times as an independent contractor, will be solely responsible for any
taxes associated with the fees paid under this Agreement with the
Services.  Neither you nor the Firm will, for any purpose, be
considered an agent or an employee of Brunswick or any of its
affiliates.   Either party will be free to terminate this
Agreement at any time on thirty days’ prior written notice.

    


    If you
are in agreement with the terms outlined in this letter, please sign and date
this letter where indicated below and return a copy to me.

    


    Pat, we
are grateful that you are willing to assist us with the Project, and look
forward to working with you.

    


    Very
truly yours,

    
      
        	
                By:

              
	 
      	
                /s/
      DUSTAN E. MCCOY

              
	 
      	
                Dustan
      E. McCoy

              


      

    

    


     

    Agreed
and acknowledged:

     

    Inisfail
Consulting

     

    
      	
              By:

            	 
      	 
      
	 
      	
              /s/
      PATRICK C. MACKEY

            	 
      	
              October
      9, 2008

            
	 
      	
              Patrick
      C. Mackey

            	 
      	
              Date

            


    

    


    
    

     

    
      	 Cc:	 Russ
      Lockridge
	 	 John
      Pfeiffer
Order entered March 31, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00207-CR

STEPHANIE ANN SCHENK, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 380th Judicial District Court

Collin County, Texas

Trial Court Cause No. 380-82013-2012

ORDER

Appellant’s motion for extension of time to file a motion for rehearing is GRANTED. 

Appellant’s motion for rehearing shall be filed by April 16, 2015. 

/s/ DAVID L. BRIDGES 

JUSTICE
**EXHIBIT 31.3**

 

**CERTIFICATIONS**

 

I, Samuel Spadafora, certify that: 

 

1.  I have reviewed this Transition Report on Form 10-K/T of Chordiant Software, Inc.; 

 

2.  Based on my knowledge, this transitional report does notcontain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by thistransitional report; 

 

3.  Based on my knowledge, thefinancial statements, and other financial information included in this transitional report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presentedin this transitional report; 

 

4.  Theregistrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: 

 

a.  designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this transitional report is being prepared; 

 

b.  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report ourconclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this transitional report, based on such evaluation; 

 

c.  Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during registrant’s most recent fiscal quarter (the registrant’s third quarter in the case of a transition report) that has materially affected, or is reasonably likely to affect, the registrant’s internalcontrol over financial reporting; and 

 

5.  Theregistrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (orpersons performing the equivalent functions): 

 

a.  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,summarize and report financial information; and 

 

b.  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
1 WO 

2 

3 

4 

5 

6 

7 

8 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

9 United States of America, No. CR-18-08088-01-PCT-CRP 

10 Plaintiff, ORDER 

11 V . 

12 Justin Wade Jones, 

13 

14 

Defendant. 

- --------- - ----- ~ 

15 The defendant appeared in court with counsel. The defendant's probable cause 

16 hearing was waived, and the detention hearing was submitted on the record including a 

17 proffer by defense counsel. The Court finds probable cause to believe the defendant 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

violated the terms of his supervised release as alleged in the petition. The Court further 

finds, pursuant to Rule 32.l(a)(6), that defendant has failed to show by clear and 

convincing evidence that he is not a flight risk or a danger. 

IT IS HEREBY ORDERED that the defendant shall be bound over for further 

proceedings on the petition to revoke his supervised release. 

IT IS FURTHER ORDERED that the defendant is detained as a flight risk and a 

danger, pending further revocation proceedings. 

Dated this 8th day of February, 2019. 

HonorabeLesie A.()wman 

United States Magistrate Judge
[Federal Register Volume 61, Number 114 (Wednesday, June 12, 1996)]
[Notices]
[Page 29769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-14795]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for Aids Drug 
Development

    Notice is hereby given that, on May 24, 1996, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. Sec. 4301 et seq. (``the Act''), Inter Company Collaboration 
for Aids Drug Development (The Collaboration) filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission reflecting changes in membership. The notifications 
were filed for the purpose of extending the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances. The changes are that Triangle Pharmaceuticals, Inc., of 
Durham, North Carolina and Agouron Pharmaceuticals, Inc., of La Jolla, 
California, have become members of the Collaboration.
    No other changes have been made in either the membership or planned 
activities of the Collaboration. Membership in the Collaboration 
remains open, and the Collaboration intends to file additional written 
notifications disclosing all changes in membership.
    On My 27, 1993, the Collaboration filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on July 6, 1993 (58 FR 36223).
    The last notification was filed with the Department on May 18, 
1995. A notice was published in the Federal Register on February 23, 
1996 (61 FR 7019).
Constance K. Robinson,
Director of Operations Antitrust Division.
[FR Doc. 96-14795 Filed 6-11-96; 8:45 am]
BILLING CODE 4410-01-M
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

 

IT IS ORDERED setting Sentencing on November 19, 2018 at 11:00 a.m. 

IT IS FURTHER ORDERED no more than ten (10) character letters shall be 

submitted by Defense Counsel in criminal cases, unless otherwise ordered by the Court. 

IT IS FURTHER ORDERED original letters must be submitted by Defense 

Counsel in paper form with the original to the U.S. Probation Office and copies to the 

Court and opposing counsel at least five (5) business days prior to the hearing. Character 

letters shall not be mailed directly to the Court by any family members or other persons 

writing in support of the Defendant. Character letters or a notice of such shall not be filed 

electronically unless otherwise ordered by the Court. 

IT IS FURTHER ORDERED that any motions for upward departure, downward 

departure and sentencing memoranda must be filed, at least, seven (7) business days prior 

to the sentencing date. Responses are due three (3) business days prior to the sentencing 

date. Any motion to continue sentencing must be filed promptly upon discovery of the 

United States of America, 

 

Plaintiff, 

vs. 

Dan Hyer, 

Defendant. 

 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

No. CR-18-0422-05-PHX-SPL

ORDER 

 

Case 2:18-cr-00422-DJH Document 272 Filed 08/17/18 Page 1 of 2
2 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

cause for continuance and must state the cause with specificity. Motions to continue 

sentencing filed less than fourteen (14) days before sentencing are disfavored. 

 Dated this 17th day of August, 2018. 

Honorable Steven P. Logan

United States District Judge

Case 2:18-cr-00422-DJH Document 272 Filed 08/17/18 Page 2 of 2